Abstract
Rectal microbicides, formulated as a gel to be applied before and/or after intercourse, are promising HIV prevention agents and are now in Phase II trials. However, both an optimal formulation and a practical delivery system are needed to ensure that the target population will use the product once efficacy is demonstrated. The precise dynamics of lubricant application by gay and bisexual men who practice anal sex and the qualities they seek in these products are underexplored. As part of a Phase I microbicide acceptability and adherence study conducted in one Puerto Rican and two continental U.S. cities, we recruited 124 young men who have sex with men (YMSM) with a history of unprotected receptive anal intercourse (RAI) and provided them with 40 rectal applicators containing a placebo gel to use prior to RAI during a 12-week period as a proxy for an eventual rectal microbicide. Ninety-five YMSM completed the trial. Their varied preferences as to product viscosity, durability, residue, and mode of application provide important lessons for the design of a product that will be satisfactory to users. Despite many reservations, the participants used the product frequently and found ways to overcome a range of obstacles. A successful rectal microbicide product may need to be presented in a range of viscosities to attract a broad client base.
Similar content being viewed by others
References
Beyrer, C., Baral, S. D., van Friensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012). Global epidemiology of HIV infection in men who have sex with men. Lancet, 380(9839), 367–377. doi:10.1016/S0140-6736(12)60821-6.
Butler, L. M., Osmond, D. H., Graves Jones, A., & Martin, J. N. (2009). Use of saliva as a lubricant in anal sexual practices among homosexual men. Journal of Acquired Immune Deficiency Syndromes, 50(2), 162–167.
Carballo-Dieguez, A., Dolezal, C., Bauermeister, J. A., O’Brien, W., Ventuneac, A., & Mayer, K. (2008). Preference for gel over suppository as delivery vehicle for a rectal microbicide: Results of a randomised, crossover acceptability trial among men who have sex with men. Sexually Transmitted Infections, 84(6), 483–487.
Carballo-Diéguez, A., Giguere, R., Dolezal, C., Bauermeister, J.A., Leu, C-S., Valladares, J., … McGowan, I. (2014a). Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: Implications for microbicide research. AIDS and Behavior, 18(9), 1726–1733. doi:10.1007/s10461-014-0768-1.
Carballo-Dieguez, A., Giguere, R., Dolezal, C., Bauermeister, J.A., Leu, C-S., Valladares, J., … Meyer, K. (2014b). Rectal-specific microbicide applicator: Evaluation and comparison with a vaginal applicator used rectally. AIDS and Behavior, 18(9), 1734–1745. doi:10.1007/s10461-014-0793-0.
Carballo-Diéguez, A., Ventuneac, A., Dowsett, G.W., Balan, I., Bauermeister, J.A., Remien, R., … Mabragaña, M. (2011). Sexual pleasure and intimacy among men who engage in “bareback sex.” AIDS and Behavior, 15(1 Suppl.), S57–S65. doi:10.1007/s10461-011-9900-7.
Clark, J.L., Salvatierra, H.J., Segura, E.R., Salazar, X., Konda, K., Galea, J., … Caceres, C.F. (2013). Frequency, patterns, and preferences of lubricant use during anal intercourse within male sexual partnerships in Lima, Peru: Implications for a rectal microbicide HIV prevention intervention. AIDS Care, 25(5), 579–585.
Coly, A., & Gorbach, P. M. (2008). Microbicide acceptability research: Recent findings and evolution across phases of product development. Current Opinion in HIV and AIDS, 3(5), 581–586.
Galea, J. T., Kinsler, J. J., Imrie, J., Nureña, C. R., Sánchez, J., & Cunningham, W. E. (2014). Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: A qualitative study. Sexually Transmitted Infections, 90(1), 33–35. doi:10.1136/sextrans-2013-051154.
Giguere, R., Carballo-Diéguez, A., Ventuneac, A., Mabragaña, M., Dolezal, C., Chen, B. A., & McGowan, I. (2012). Variations in microbicide gel acceptability among young women in the USA and Puerto Rico. Culture, Health & Sexuality, 14(2), 151–166.
Hsieh, H. -F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288.
Javanbakht, M., Murphy, R., Gorbach, P., LeBlanc, M.-A., & Pickett, J. (2010). Preference and practices relating to lubricant use during anal intercourse: Implications for rectal microbicides. Sexual Health, 7(2), 193–198.
Javanbakht, M., Stahlman, S., Pickett, J., LeBlanc, M-A., & Gorbach, P.M. (2014). Prevalence and types of rectal douches used for anal intercourse: Results from an international survey. BMC Infectious Diseases, 14, 95. http://www.biomedcentral.com/1471-2334/14/95.
Jones, D. L., Weiss, S. M., Chitalu, N., Mumbi, M., Shine, A., Vamos, S., & Villar, O. (2008). Acceptability and use of sexual barrier products and lubricants among HIV-seropositive Zambian men. AIDS Patient Care & STDs, 22(12), 1015–1020. doi:10.1089/apc.2007.0212.
Kinsler, J.J., Cunningham, W.E., Nureña, C.R., Nadjat-Haiem, C., Grinsztejn, B., Casapia, M., … Galea, J. (2012). Using conjoint analysis to measure the acceptability of rectal microbicides among MSM in four South American cities. AIDS and Behavior, 16(6), 1436–47.
Kinsler, J. J., Galea, J. T., Peinado, J., Segura, P., Montano, S. M., & Sánchez, J. (2010). Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: Implications for rectal microbicides as an HIV prevention strategy. International Journal of STD and AIDS, 21, 567–572.
Marks, G., Mansergh, G., Crepaz, N., Murphy, S., Miller, L. C., & Appleby, P. R. (2000). Future HIV prevention options for men who have sex with men: Intention to use a potential microbicide during anal intercourse. AIDS and Behavior, 4(3), 279–287.
McGowan, I. (2011). Rectal microbicides: Can we make them and will people use them? AIDS and Behavior, 15(Suppl. 1), S66–S71. doi:10.1007/s10461-011-9899-9.
McGowan, I., Cranston, R. D., Duffill, K., Siegel, A., Engstrom, J. C., Nikiforov, A., … Anton, P. A. (2015). A phase 1 randomized, open label, rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of three formulations of tenofovir 1% gel (the CHARM-01 study). PLoS One, 10(5), e0125363.
Pines, H. A., Gorbach, P. M., Reback, C. J., Landovitze, R. J., Mutchler, M. G., & Mitsuyasue, R. (2014). Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: Implications for the development of rectal microbicides for HIV prevention. AIDS Care, 26(12), 1609–1618. doi:10.1080/09540121.2014.936821.
Pines, H.A., Gorbach, P.M., Weiss, R.E., Hess, K., Murphy, R., Saunders, T., … Cranston, R.D. (2013). Acceptability of potential rectal microbicide delivery systems for HIV prevention: A randomized crossover trial. AIDS and Behavior, 17(3), 1002–1015.
Tolley, E. E., & Severy, L. J. (2006). Integrating behavioral and social science research into microbicide clinical trials: Challenges and opportunities. American Journal of Public Health, 96(1), 79–83.
van Griensven, F., & van Wijngaarden, J. W. L. (2010). A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. (2010). AIDS, 24(Suppl. 3), S30–S40.
Ventuneac, A., Carballo-Diéguez, A., McGowan, I., Dennis, R., Adler, A., Khanukhova, E., … Anton P. (2010). Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. AIDS and Behavior, 14(3), 618–628.
Acknowledgments
This research was sponsored by the US National Institutes of Health (NIH), including NICHD and NIMH, under R01 HD59533 (Carballo-Diéguez and McGowan, Co-PIs) and co-sponsored by CONRAD. Additional support came from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University (P30-MH43520; Principal Investigator: Robert H. Remien).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Frasca, T., Giguere, R., Ibitoye, M. et al. Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse. Arch Sex Behav 46, 1101–1109 (2017). https://doi.org/10.1007/s10508-016-0735-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-016-0735-1